Alyeska Investment Group »

Benitec Biopharma shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $10M 750k 13.47

More positions owned by Alyeska Investment Group

Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Boeing Company (BA)
Take-Two Interactive Software (TTWO)
Doordash Cl A (DASH)
Burlington Stores (BURL)
Equinix (EQIX)
Danaher Corporation (DHR)
Broadcom (AVGO)
Meta Platforms Cl A (META)
At&t (T)
Coreweave Com Cl A (CRWV)
Kroger (KR)
McDonald's Corporation (MCD)

View all positions for Alyeska Investment Group

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Franklin Resources
Adage Capital Partners GP
Vanguard Group
BlackRock
Nantahala Capital Management
Alyeska Investment Group
Infinitum Asset Management
Geode Capital Management
Silverarc Capital Management
Schonfeld Strategic Advisors
State Street Corporation
AWM Investment Company
Goldman Sachs Group

View all funds holding Benitec Biopharma